EU institutions should engage more politically to induce change in HIV awareness
14 Jul 2017 – 10:30 | No Comment

Nearly 122,000 are unaware of their HIV infection in Europe. To decrease the number of people who are diagnosed late or are unaware of their infection, new strategies are required to expand targeted HIV testing …

Read the full story »
International

EU Health

Transport

Circular Economy

Climate Change

Home » Archive by Tags

Articles tagged with: Bladder Cancer

What should Europe start, stop and do collectively with bladder cancer?
30 Sep 2016 – 17:37
What should Europe start, stop and do collectively with bladder cancer?

In the UK, around 98,000 people are living with bladder cancer and over 10,000 new cases are diagnosed every year with 5,000 deaths. In the EU, there are approximately 123,135 new cases and 40,252 deaths …

European Commission’s fight against cancer grows stronger
30 Sep 2016 – 17:25
European Commission’s fight against cancer grows stronger

The European Commission aims to reduce the burden of cancer through the Joint Action CANCON (European Guide on Quality Improvement in Comprehensive Cancer Control), European Code Against Cancer and by heavily investing on research. Antoni …

Reducing risk factors for bladder cancer: the legislator’s role
30 Sep 2016 – 17:17
Reducing risk factors for bladder cancer: the legislator’s role

Discussing the legislator’s role in beating bladder cancer, Daciana Octavia Sarbu MEP says a broader strategy including, emissions from road traffic and pesticide limits is equally important if we are to control risk factors for …

Measuring the value of care in the management of bladder cancer
30 Sep 2016 – 17:15
Measuring the value of care in the management of bladder cancer

How should we define success in disease management and track the level of achievement in order to continuously improve the health care system to be functional and sustainable? Dr. Zenichi Ihara, Health Economics Manager, Commercial …

EU acts against work related cancer
30 Sep 2016 – 17:13
EU acts against work related cancer

The most common cause of work-related deaths in the EU is cancer and bladder cancer was one of the first cancers to be linked to occupation. The European Commission recently proposed changes to the Carcinogens …

Screening for bladder cancer: rationale and perspectives
30 Sep 2016 – 17:10
Screening for bladder cancer: rationale and perspectives

Bladder Cancer screening is currently not recommended in routine practice partly because of low overall incidence. However, Prof Morgan Roupret, Professor, Université Paris, believes that rational screening policies for smaller groups of people based on …

Industries at risk of bladder cancer within Europe
30 Sep 2016 – 17:10
Industries at risk of bladder cancer within Europe

Several occupations have an elevated risk of bladder cancer. The highest risks occur in workers within tobacco manufacture, dye and rubber production, nurses, hairdressers and radiation workers. Prof James W.F. Catto, Professor of Urology at the …

Vicinium: A recombinant targeted protein therapeutic for Non-muscle invasive bladder cancer
30 Sep 2016 – 17:08
Vicinium: A recombinant targeted protein therapeutic for Non-muscle invasive bladder cancer

Vicinium is currently being evaluated in a single arm, registrational phase 3 clinical trial in the USA and Canada in patients with high grade Non Muscle Invasive Bladder Cancer (NMIBC). Dr Gregory Adams, Chief Development …

Roche confirms its commitment to address the needs of patients with bladder cancer
30 Sep 2016 – 17:01
Roche confirms its commitment to address the needs of patients with bladder cancer

Recognising the need for consolidated focus on bladder cancer patients’ needs, Roche supports an opportunity for broad collaboration engaging professional societies, nurses, patient organisations and various European institutions. Pablo Perez-Moreno, International Medical Director – Oncology …

Managing bladder cancer in the elderly
30 Sep 2016 – 17:00
Managing bladder cancer in the elderly

‘At the present point, only about half of all MIBC patients are in a position to be fully cured of their cancer 5 years after diagnosis.’ Dr Anne E Kiltie, Associate Professor, Department of Oncology, …